Step by Stepa HemeOncBuddy patient portal

AC and dose-dense AC

Illustration: AC and dose-dense AC

Say it: A-C

Doxorubicin and cyclophosphamide

AC is a 2 medicine chemotherapy for early stage breast cancer, given every 3 weeks or every 2 weeks (dose dense), and usually followed by paclitaxel.

Also called: AC, dose-dense AC, ddAC, AC-T, AC then paclitaxel, Adriamycin Cytoxan, red devil chemo, AC every 2 weeks

What it is

Doxorubicin and cyclophosphamide damage cancer cell DNA in different ways. The goal is cure: to kill cancer cells that may have spread and lower the chance the cancer comes back. AC is most often given for 4 cycles and then followed by a taxane (paclitaxel or docetaxel), a plan called AC-T.

AAdriamycin (doxorubicin)
Ccyclophosphamide

Often used for

Dose-dense AC
The same medicines given every 2 weeks instead of every 3 weeks, with pegfilgrastim after each dose. Giving it closer together works a little better for some higher risk cancers.
AC then paclitaxel (AC-T)
After 4 cycles of AC, paclitaxel is given weekly for 12 weeks or every 2 weeks for 4 doses. This is the most common way AC is used.
AC with pembrolizumab
For some triple negative breast cancers treated before surgery, immunotherapy (pembrolizumab) is added along with carboplatin and paclitaxel, then AC.
Every 3 week AC
The standard schedule, given every 21 days for 4 cycles. A white blood cell shot may or may not be needed.

The medicines in this plan

Doxorubicin (Adriamycin)
An anthracycline chemotherapy (a red medicine, sometimes called the red devil). Given through a vein over a few minutes on day 1.
Cyclophosphamide
An alkylating chemotherapy. Given through a vein over about 30 to 60 minutes on day 1.
Pegfilgrastim
A shot that boosts white blood cells. Given the day after treatment, or by an on body injector placed on day 1. Required for dose-dense AC.

How you get it

AC is given in an outpatient infusion clinic. A treatment day takes about 2 to 3 hours. You usually get 4 cycles, either every 21 days (about 12 weeks) or every 14 days with dose-dense AC (about 8 weeks). Many people get a port. Your schedule may be different.

A typical cycle

Day 1
Blood tests, then nausea medicines, then IV doxorubicin and cyclophosphamide.
Day 2
Pegfilgrastim shot, or the on body injector gives it for you. This is needed for dose-dense AC.
Days 2 to 5
Nausea and tiredness are most common now. Urine may look red for a day or two.
Days 7 to 12
White blood cells are lowest. Watch for fever.
Day 14 or 21
Next cycle starts (day 15 for dose dense, day 22 for every 3 weeks).

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Breast cancer

Sources

Quick answers

What is AC and dose-dense AC?
AC is a 2 medicine chemotherapy for early stage breast cancer, given every 3 weeks or every 2 weeks (dose dense), and usually followed by paclitaxel. Doxorubicin and cyclophosphamide.
What does AC and dose-dense AC stand for?
A = Adriamycin (doxorubicin); C = cyclophosphamide.
How is AC and dose-dense AC given?
AC is given in an outpatient infusion clinic. A treatment day takes about 2 to 3 hours. You usually get 4 cycles, either every 21 days (about 12 weeks) or every 14 days with dose-dense AC (about 8 weeks). Many people get a port. Your schedule may be different.
What are the common side effects of AC and dose-dense AC?
Hair loss, usually complete and starting about 2 to 3 weeks after the first dose. Nausea and vomiting. Feeling very tired, often building with each cycle. Low white blood cells and a higher risk of infection. Mouth sores. Red or pink urine for 1 to 2 days. Changes in periods, or periods stopping. Bone pain from the pegfilgrastim shot. Changes in taste.
When should I call my care team during AC and dose-dense AC?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Vomiting that keeps you from drinking for a day, or signs of dehydration; Pain or blood when you urinate; Shortness of breath, chest pain, swelling in your legs, or a racing heartbeat; Pain, redness, swelling or blistering where the IV went in; Bleeding or many new bruises; Mouth sores that keep you from eating or drinking.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.